Product Description
PT-141 stimulates melanocortin receptors in the brain, promoting sexual desire in both male and female models. This central action differentiates it from peripheral-targeting therapies and makes it highly relevant in sexual health research.
PT-141 modulates neurohormonal pathways, influencing dopamine, melanocortin, and other neurotransmitter systems that regulate sexual behavior, stress response, and mood.
Research indicates PT-141 has fast onset effects in preclinical models, with central nervous system activity that bypasses cardiovascular pathways common in other sexual function therapies.
PT-141 is highly purified, well-characterized, and demonstrates minimal toxicity in experimental settings, suitable for both in vitro and in vivo studies.
Beyond sexual health, PT-141 is explored in neuroscience and behavioral research due to its effects on motivational and reward pathways.
| Parameter | Description |
| CAS Number | 189691-06-3 |
| Product Name | PT-141 (Bremelanotide) |
| Molecular Formula | C₅₁H₆₉N₁₃O₁₀ |
| Molecular Weight | 841.0 g/mol |
| Amino Acid Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Appearance | White to off-white lyophilized powder |
| Storage | Store at –20°C, protected from light |
| Specification | Option |
| Purity | ≥98% (HPLC) |
| Form | Lyophilized powder |
| Vial Sizes | 1 mg, 5 mg, 10 mg, 50 mg (custom options available) |
| Packaging | Sterile sealed vials; moisture-resistant, temperature-controlled packaging |
| Shelf Life | 24 months under recommended storage conditions |
PT-141 is widely investigated for its effects on sexual desire, arousal, and reproductive behaviors in preclinical and clinical models.
Its modulation of melanocortin and dopaminergic pathways makes PT-141 valuable for research into neurohormonal regulation and brain signaling mechanisms.
PT-141’s effects on reward and motivation systems allow it to be used in neuroscience and behavioral research.
PT-141 provides a research model for developing therapies targeting male and female sexual dysfunction, hormone-regulated reproductive pathways, and libido enhancement.
PT-141 serves as a key experimental compound in the development of peptide-based drugs for sexual health, neuroendocrine modulation, and behavioral interventions.
